葛兰素史克-3
化学
糖原合酶
激酶
苏氨酸
丝氨酸
酶
选择性
GSK3B公司
生物化学
信号转导
药理学
生物
催化作用
作者
Junxia Wei,Jiaxing Wang,Jifa Zhang,Jinliang Yang,Guan Wang,Yuxi Wang
标识
DOI:10.1016/j.ejmech.2022.114301
摘要
Glycogen synthase kinase-3β (GSK-3β) is a conserved serine/threonine kinase that participates in the transmission of multiple signaling pathways and plays an important role in the occurrence and development of human diseases, such as metabolic diseases, neurological diseases and cancer, making it to be a potential and promising drug target. To date, copious GSK-3β inhibitors have been synthesized, but only few have entered clinical trials. Most of them exerts poor selectivity, concomitant off-target effects and side effects. This review summarizes the structural characteristics, biological functions and relationship with diseases of GSK-3β, as well as the selectivity profile and therapeutic potential of different categories of GSK-3β inhibitors. Strategies for increasing selectivity and reducing adverse effects are proposed for the future design of GSK-3β inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI